This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2fhy
From Proteopedia
(New page: 200px<br /> <applet load="2fhy" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fhy, resolution 2.95Å" /> '''Structure of human ...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2fhy.gif|left|200px]]<br /> | + | [[Image:2fhy.gif|left|200px]]<br /><applet load="2fhy" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2fhy" size=" | + | |
caption="2fhy, resolution 2.95Å" /> | caption="2fhy, resolution 2.95Å" /> | ||
'''Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor'''<br /> | '''Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor'''<br /> | ||
==Overview== | ==Overview== | ||
| - | We have identified benzoxazole benzenesulfonamide 1 as a novel allosteric | + | We have identified benzoxazole benzenesulfonamide 1 as a novel allosteric inhibitor of fructose-1,6-bisphosphatase (FBPase-1). X-ray crystallographic and biological studies of 1 indicate a distinct binding mode that recapitulates features of several previously reported FBPase-1 inhibitor classes. |
==Disease== | ==Disease== | ||
| - | Known disease associated with this structure: Fructose- | + | Known disease associated with this structure: Fructose-1,6-bidphosphatase deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=611570 611570]] |
==About this Structure== | ==About this Structure== | ||
| - | 2FHY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with MG and A37 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Fructose-bisphosphatase Fructose-bisphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.11 3.1.3.11] Full crystallographic information is available from [http:// | + | 2FHY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=MG:'>MG</scene> and <scene name='pdbligand=A37:'>A37</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Fructose-bisphosphatase Fructose-bisphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.11 3.1.3.11] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FHY OCA]. |
==Reference== | ==Reference== | ||
| Line 25: | Line 24: | ||
[[Category: intersubunit allosteric inhibition of human fpbase]] | [[Category: intersubunit allosteric inhibition of human fpbase]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:21:36 2008'' |
Revision as of 15:21, 21 February 2008
|
Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitor
Contents |
Overview
We have identified benzoxazole benzenesulfonamide 1 as a novel allosteric inhibitor of fructose-1,6-bisphosphatase (FBPase-1). X-ray crystallographic and biological studies of 1 indicate a distinct binding mode that recapitulates features of several previously reported FBPase-1 inhibitor classes.
Disease
Known disease associated with this structure: Fructose-1,6-bidphosphatase deficiency OMIM:[611570]
About this Structure
2FHY is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as Fructose-bisphosphatase, with EC number 3.1.3.11 Full crystallographic information is available from OCA.
Reference
Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode., von Geldern TW, Lai C, Gum RJ, Daly M, Sun C, Fry EH, Abad-Zapatero C, Bioorg Med Chem Lett. 2006 Apr 1;16(7):1811-5. Epub 2006 Jan 25. PMID:16442285
Page seeded by OCA on Thu Feb 21 17:21:36 2008
